Inhibition of lymphatic metastases by a survivin dominant-negative mutant.

Abstract excerpt

Metastasis is the most lethal attribute of human malignancy. High-level expression of survivin is involved in both carcinogenesis and angiogenesis in cancer. Previous studies indicate that a mutation of the threonine residue at position 34 (Thr34Ala) of survivin generates a dominant-negative mutant that induces apoptosis, inhibits angiogenesis, and suppresses highly metastatic breast carcinoma in mouse models. We...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genetic Therapy
• Share to Inhibitor of Apoptosis Proteins